Alkermes plc. Contract with Customer, Liability, Noncurrent
Alkermes plc. (ALKS) had Contract with Customer, Liability, Noncurrent of $11.49 million as of 2021-12-31, per its 10-K filed 2022-02-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2022-02-16
- 2021-12-31: Contract with Customer, Liability, Noncurrent $11.49M.
- 2021-09-30: Contract with Customer, Liability, Noncurrent $12.86M.
- 2021-06-30: Contract with Customer, Liability, Noncurrent $14.17M.
- 2021-03-31: Contract with Customer, Liability, Noncurrent $14.74M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2021-12-31 | $11.49M 10-K · filed 2022-02-16 |
| 2021-09-30 | $12.86M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $14.17M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $14.74M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $16.40M 10-K · filed 2022-02-16 |
| 2020-09-30 | $18.64M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $18.88M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $21.16M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $22.07M 10-K · filed 2021-02-11 |
| 2019-09-30 | $11.19M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $11.62M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $11.34M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $9.53M 10-K · filed 2020-02-13 |
| 2018-09-30 | $5.01M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $5.86M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $6.17M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $5.66M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |